According to a study published by The Lancet Infectious Diseases, researchers estimated that globally 3 in every 1,000 people carry latent multidrug-resistant tuberculosis (MDR-TB), with the prevalence of being 10 times higher among children younger than 15 years of age.
As outlined in the independent review on Antimicrobial Resistance, AMR is predicted to kill 10 million people every year by 2050 without action. From rare pathogens to pandemic prevention, explore the latest techniques and technologies that are shaping today’s diagnosis and treatment of infectious diseases.
Our speaker panel will address challenges associated with infectious diseases and discuss about emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance.
The congress will attract Directors, Heads of Laboratory, Chief Scientists, Professors, Consultant Microbiologist and many stakeholder of the diagnostics industry
The 3rd Annual MarketsandMarkets Infectious Diseases Diagnostics Conference taking place in London – UK aims to bring different stakeholders together from hospitals, laboratories academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations, brainstorming panel discussion and case studies will give the stakeholders an opportunity to discuss and understand the issues faced.
